Literature DB >> 11450284

Antiretroviral therapy cannot be South Africa's first priority.

D J Ncayiyana1.   

Abstract

Mesh:

Substances:

Year:  2001        PMID: 11450284      PMCID: PMC81196     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  3 in total

Review 1.  Access to essential medications for HIV/AIDS in South Africa.

Authors:  S Andrews
Journal:  S Afr Med J       Date:  2001-05

2.  Effect of highly active antiretroviral therapy on diagnoses of sexually transmitted diseases in people with AIDS.

Authors:  S Scheer; P L Chu; J D Klausner; M H Katz; S K Schwarcz
Journal:  Lancet       Date:  2001-02-10       Impact factor: 79.321

3.  Independent epidemics of heterosexual and homosexual HIV infection in South Africa--survival differences.

Authors:  G Maartens; R Wood; E O'Keefe; C Byrne
Journal:  QJM       Date:  1997-07
  3 in total
  4 in total

1.  Canada's commitment to AIDS relief in Africa.

Authors: 
Journal:  CMAJ       Date:  2001-06-26       Impact factor: 8.262

2.  Drug companies should be held more accountable for their human rights responsibilities.

Authors: 
Journal:  PLoS Med       Date:  2010-09-28       Impact factor: 11.069

3.  Challenges of access to medicine and the responsibility of pharmaceutical companies: a legal perspective.

Authors:  Saeed Ahmadiani; Shekoufeh Nikfar
Journal:  Daru       Date:  2016-05-04       Impact factor: 3.117

Review 4.  Unlocking Access To Novel Medicines In China-A Review From A Health System Perspective.

Authors:  Yifan Diao; Mingshuang Li; Zhiran Huang; Jing Sun; Yoke Ling Chee; Yunali Liu
Journal:  Risk Manag Healthc Policy       Date:  2019-12-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.